{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:42:25Z","timestamp":1780656145445,"version":"3.54.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.drudis.2016.06.011","type":"journal-article","created":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T02:08:11Z","timestamp":1466474891000},"page":"1620-1631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Chemistry and clinical relevance of carbohydrate degradation in drugs"],"prefix":"10.1016","volume":"21","author":[{"given":"Monika","family":"Pischetsrieder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Gensberger-Reigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Atzenbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2016.06.011_bib0530","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00134-010-1873-x","article-title":"Infusion fluids contain harmful glucose degradation products","volume":"36","author":"Bryland","year":"2010","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.drudis.2016.06.011_bib0535","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.jrn.2011.10.014","article-title":"Chemical and physiological relevance of glucose degradation products in peritoneal dialysis","volume":"22","author":"Mittelmaier","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"10.1016\/j.drudis.2016.06.011_bib0540","first-page":"17","article-title":"A chromatographic quality control procedure based on HPLC for 5-hydroxymethylfurfural in autoclaved d-glucose infusion fluids","volume":"7","author":"Hung","year":"1982","journal-title":"J. Clin. Hosp. Pharm."},{"key":"10.1016\/j.drudis.2016.06.011_bib0545","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0021-9673(01)93992-5","article-title":"Reversed-phase high-performance liquid chromatographic method for the quantification of 5-hydroxymethylfurfural as the major degradation product of glucose in infusion fluids","volume":"467","author":"Cook","year":"1989","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.drudis.2016.06.011_bib0550","first-page":"181","article-title":"3-Deoxyglycosuloses (3-deoxyglycosones) and the degradation of carbohydrates","volume":"19","author":"Anet","year":"1964","journal-title":"Adv. Carbohydr. Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0555","first-page":"290","article-title":"3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis","volume":"18","author":"Linden","year":"1998","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0560","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1523-1755.2002.00490.x","article-title":"3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis","volume":"62","author":"Linden","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0565","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/bmc.1194","article-title":"Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids","volume":"23","author":"Frischmann","year":"2009","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.drudis.2016.06.011_bib0570","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00216-011-5195-9","article-title":"Quantification of the six major alpha-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC\/DAD\/MSMS","volume":"401","author":"Mittelmaier","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0575","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00216-010-4456-3","article-title":"3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: Identification, quantification by HPLC\/DAD\/MSMS and its pathway of formation","volume":"399","author":"Mittelmaier","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0580","doi-asserted-by":"crossref","first-page":"10752","DOI":"10.1021\/jf102388v","article-title":"3-Deoxygalactosone, a \u2018new\u2019 1,2-dicarbonyl compound in milk products","volume":"58","author":"Hellwig","year":"2010","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0585","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/089686089301300309","article-title":"Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes","volume":"13","author":"Nilsson-Thorell","year":"1993","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0590","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/089686080502500615","article-title":"Take care in how you store your PD fluids: actual temperature determines the balance between reactive and non-reactive GDPs","volume":"25","author":"Erixon","year":"2005","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0595","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jchromb.2010.02.004","article-title":"Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC\/DAD\/MSMS","volume":"878","author":"Mittelmaier","year":"2010","journal-title":"J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.drudis.2016.06.011_bib0600","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3440109","article-title":"Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose","volume":"344","author":"Thornalley","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.drudis.2016.06.011_bib0605","doi-asserted-by":"crossref","first-page":"10198","DOI":"10.1021\/jf305117s","article-title":"Fragmentation pathways during Maillard-induced carbohydrate degradation","volume":"61","author":"Smuda","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0610","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1021\/jf9019085","article-title":"Degradation of glucose: reinvestigation of reactive \u03b1-dicarbonyl compounds","volume":"57","author":"Gobert","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0615","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/089686080202200309","article-title":"How to reduce 3-deoxyglucosone and acetaldehyde in peritoneal dialysis fluids","volume":"22","author":"Zimmeck","year":"2002","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0620","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1021\/jf010148h","article-title":"Detection of alpha-dicarbonyl compounds in Maillard reaction systems and in vivo","volume":"49","author":"Glomb","year":"2001","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0625","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1021\/jf3048466","article-title":"Analysis of sugar degradation products with alpha-dicarbonyl structure in carbonated soft drinks by UHPLC\u2013DAD\u2013MS\/MS","volume":"61","author":"Gensberger","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0630","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/089686080902900402","article-title":"Icodextrin metabolites in peritoneal dialysis","volume":"29","author":"Garcia-Lopez","year":"2009","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0635","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2165\/00003495-200363190-00011","article-title":"Icodextrin: a review of its use in peritoneal dialysis","volume":"63","author":"Frampton","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.drudis.2016.06.011_bib0640","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1046\/j.1523-1755.2000.00436.x","article-title":"Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids","volume":"58","author":"Ueda","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0645","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jf00027a002","article-title":"Maillard reactions of lactose and maltose","volume":"41","author":"Kramh\u00f6ller","year":"1993","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0650","first-page":"14","article-title":"Advanced Maillard products of disaccharides: analysis and relation to reaction conditions","volume":"vol 631","author":"Pischetsrieder","year":"1996"},{"key":"10.1016\/j.drudis.2016.06.011_bib0655","doi-asserted-by":"crossref","first-page":"13254","DOI":"10.1021\/jf203346b","article-title":"Novel insights into the Maillard catalysed degradation of maltose","volume":"59","author":"Smuda","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0660","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1021\/jf011107o","article-title":"3-Deoxypentosulose: an alpha-dicarbonyl compound predominating in nonenzymatic browning of oligosaccharides in aqueous solution","volume":"50","author":"Hollnagel","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0665","doi-asserted-by":"crossref","first-page":"6219","DOI":"10.1021\/jf9906127","article-title":"Degradation of oligosaccharides in nonenzymatic browning by formation of alpha-dicarbonyl compounds via a \u2018peeling off\u2019 mechanism","volume":"48","author":"Hollnagel","year":"2000","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0670","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1021\/acs.analchem.5b00665","article-title":"Comprehensive profiling of polyglucose degradation products in peritoneal dialysis fluids","volume":"87","author":"Gensberger","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0675","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1021\/ja01499a058","article-title":"4-Deoxy-3-oxo-D-glycero-2-hexulose, the dicarbonyl intermediate in the formation of d-isosaccharinic acids","volume":"82","author":"Whistler","year":"1960","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.drudis.2016.06.011_bib0680","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00217-006-0273-5","article-title":"Isolation and identification of 3,4-dideoxypentosulose as specific degradation product of oligosaccharides with 1,4-glycosidic linkages","volume":"223","author":"Mavric","year":"2006","journal-title":"Eur. Food Res. Technol."},{"key":"10.1016\/j.drudis.2016.06.011_bib0685","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jpba.2015.10.022","article-title":"Quantification of reactive carbonyl compounds in icodextrin-based peritoneals dialysis fluids by combined UHPLC-DAD and -MS\/MS detection","volume":"118","author":"Gensberger","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.drudis.2016.06.011_bib0690","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1006\/bbrc.2001.4294","article-title":"In vitro formation of N[epsilon]-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis","volume":"280","author":"Tauer","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.drudis.2016.06.011_bib0695","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/089686089201200105","article-title":"Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis","volume":"12","author":"Dobbie","year":"1992","journal-title":"Perit. Dial. Int."},{"issue":"Suppl. 5","key":"10.1016\/j.drudis.2016.06.011_bib0700","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ndt\/11.supp5.2","article-title":"Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients","volume":"11","author":"Mahiout","year":"1996","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.drudis.2016.06.011_bib0705","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.2174\/092986707780830989","article-title":"The road to advanced glycation end products: a mechanistic perspective","volume":"14","author":"Cho","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0710","first-page":"191","article-title":"Comparison of in vitro AGE formation between standard PD fluid and a novel bicarbonate\/lactate formulation","volume":"14","author":"Millar","year":"1998","journal-title":"Adv. Perit. Dial."},{"key":"10.1016\/j.drudis.2016.06.011_bib0715","doi-asserted-by":"crossref","first-page":"32299","DOI":"10.1016\/S0021-9258(18)31635-1","article-title":"Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin","volume":"269","author":"Lo","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0720","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF01192954","article-title":"Detection and identification of a protein-bound imidazolone resulting from the reaction of arginine residues and methylglyoxal","volume":"199","author":"Henle","year":"1994","journal-title":"Z. Lebensm. Unters. Forsch."},{"key":"10.1016\/j.drudis.2016.06.011_bib0725","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1172\/JCI119285","article-title":"Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients","volume":"99","author":"Niwa","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.drudis.2016.06.011_bib0730","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1021\/tx500153n","article-title":"Structure- and concentration-specific assessment of the physiological reactivity of alpha-dicarbonyl glucose degradation products in peritoneal dialysis fluids","volume":"27","author":"Distler","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.drudis.2016.06.011_bib0735","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1021\/bi00004a038","article-title":"In vivo glycation of aldehyde reductase, a major 3-deoxyglucosone reducing enzyme: identification of glycation sites","volume":"34","author":"Takahashi","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.drudis.2016.06.011_bib0740","doi-asserted-by":"crossref","first-page":"e113418","DOI":"10.1371\/journal.pone.0113418","article-title":"Influence of nonenzymatic posttranslational modifications on constitution, oligomerization and receptor binding of S100A12","volume":"9","author":"Augner","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2016.06.011_bib0745","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1074\/jbc.M410973200","article-title":"Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity","volume":"280","author":"Ahmed","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0750","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1042\/bj2960489","article-title":"Chemistry of collagen cross-links: glucose-mediated covalent cross-linking of type-IV collagen in lens capsules","volume":"296","author":"Bailey","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.drudis.2016.06.011_bib0755","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1053\/ajkd.2001.27415","article-title":"Localization of imidazolone in the peritoneum of CAPD patients: a factor for a loss of ultrafiltration","volume":"38","author":"Nakamura","year":"2001","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.drudis.2016.06.011_bib0760","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/ndt\/14.6.1541","article-title":"Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration","volume":"14","author":"Honda","year":"1999","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.drudis.2016.06.011_bib0765","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1523-1755.2004.00879.x","article-title":"Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane","volume":"66","author":"Mortier","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0770","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/089686080102100304","article-title":"Structural and functional alterations of the peritoneum after prolonged exposure to dialysis solutions: role of aminoguanidine","volume":"21","author":"Lee","year":"2001","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0775","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1046\/j.1523-1755.63.s84.31.x","article-title":"Immunohistochemical detection of an AGE, a ligand for macrophage receptor, in peritoneum of CAPD patients","author":"Nakamura","year":"2003","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.drudis.2016.06.011_bib0780","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2249.2004.02629.x","article-title":"Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products","volume":"138","author":"Lai","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.drudis.2016.06.011_bib0785","doi-asserted-by":"crossref","first-page":"9660","DOI":"10.1021\/ac2025706","article-title":"Multistep ultrahigh performance liquid chromatography\/tandem mass spectrometry analysis for untargeted quantification of glycating activity and identification of most relevant glycation products","volume":"83","author":"Mittelmaier","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0790","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1196\/annals.1433.000","article-title":"Immunological detection of N omega-(Carboxymethyl)arginine by a specific antibody","volume":"1126","author":"Mera","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.drudis.2016.06.011_bib0795","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1021\/jf103116c","article-title":"Formation of arginine modifications in a model system of N-alpha-tert-butoxycarbonyl (Boc)-arginine with methylglyoxal","volume":"59","author":"Klopfer","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0800","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ki.1991.182","article-title":"Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929","volume":"40","author":"Wieslander","year":"1991","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0805","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/089686088900900310","article-title":"Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro","volume":"9","author":"van Bronswijk","year":"1989","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0810","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1093\/ndt\/gfn273","article-title":"3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization","volume":"23","author":"Santamaria","year":"2008","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.drudis.2016.06.011_bib0815","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/ndt\/gfq484","article-title":"Peritoneal dialysis fluids can alter HSP expression in human peritoneal mesothelial cells","volume":"26","author":"Bender","year":"2011","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.drudis.2016.06.011_bib0820","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/089686080402400416","article-title":"PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization","volume":"24","author":"Erixon","year":"2004","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0825","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1774-9987.2005.00228.x","article-title":"Synergistic cytotoxicity of acidity and 3,4-dideoxyglucosone-3-ene under the existence of lactate in peritoneal dialysis fluid","volume":"9","author":"Tomo","year":"2005","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.drudis.2016.06.011_bib0830","first-page":"597","article-title":"3,4-DGE is cytotoxic and decreases HSP27\/HSPB1 in podocytes","volume":"88","author":"Sanchez-Nino","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drudis.2016.06.011_bib0835","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.2337\/diabetes.54.8.2424","article-title":"3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells","volume":"54","author":"Justo","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.drudis.2016.06.011_bib0840","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ndt\/gfn645","article-title":"Glutathione depletion as a mechanism of 3,4-dideoxyglucosone-3-ene-induced cytotoxicity in human peritoneal mesothelial cells: role in biocompatibility of peritoneal dialysis fluids","volume":"24","author":"Yamamoto","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.drudis.2016.06.011_bib0845","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000374103","article-title":"Biocompatibility reduces inflammation-induced apoptosis in mesothelial cells exposed to peritoneal dialysis fluid","volume":"39","author":"Santamaria","year":"2015","journal-title":"Blood Purif."},{"key":"10.1016\/j.drudis.2016.06.011_bib0850","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/089686080902900107","article-title":"3,4-Dideoxyglucosone-3-ene induces apoptosis in human peritoneal mesothelial cells","volume":"29","author":"Lee","year":"2009","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0855","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1046\/j.1523-1755.2003.00265.x","article-title":"Glucose degradation products (GDP) retard remesothelialization independently of d-glucose concentration","volume":"64","author":"Morgan","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0860","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.drudis.2016.06.011_bib0865","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000188837","article-title":"Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure","volume":"72","author":"Honda","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.drudis.2016.06.011_bib0870","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3747\/pdi.2011.00033","article-title":"Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice","volume":"33","author":"Yokoi","year":"2013","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0875","first-page":"343","article-title":"Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes","volume":"39","author":"Wieslander","year":"1993","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.drudis.2016.06.011_bib0880","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.1996.119","article-title":"Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum","volume":"49","author":"Niwa","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0885","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0378-4347(99)00113-9","article-title":"3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication","volume":"731","author":"Niwa","year":"1999","journal-title":"J. Chromatogr. B: Biomed. Sci. Appl."},{"key":"10.1016\/j.drudis.2016.06.011_bib0890","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1271\/bbb.59.1407","article-title":"Identification of the modified structure of arginine residues in proteins with 3-deoxyglucosone, a Maillard reaction intermediate","volume":"59","author":"Hayase","year":"1995","journal-title":"Biosci. Biotech. Biochem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0895","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mnfr.200400111","article-title":"Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis","volume":"49","author":"Tauer","year":"2005","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.drudis.2016.06.011_bib0900","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1021\/jf405546q","article-title":"Dietary influence on urinary excretion of 3-deoxyglucosone and its metabolite 3-deoxyfructose","volume":"62","author":"Degen","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.06.011_bib0905","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1523-1755.2005.00528.x","article-title":"3,4-Di-deoxyglucosone-3-ene promotes leukocyte apoptosis","volume":"68","author":"Catalan","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0910","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/089686089901900408","article-title":"Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids","volume":"19","author":"Schalkwijk","year":"1999","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0915","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/089686080102100612","article-title":"Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells","volume":"21","author":"Linden","year":"2001","journal-title":"Perit. Dial. Int."},{"issue":"Suppl. 5","key":"10.1016\/j.drudis.2016.06.011_bib0920","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1177\/089686080002005S05","article-title":"Biological significance of reducing glucose degradation products in peritoneal dialysis fluids","volume":"20","author":"Wieslander","year":"2000","journal-title":"Perit. Dial. Int."},{"issue":"Suppl. 2","key":"10.1016\/j.drudis.2016.06.011_bib0925","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1177\/089686080902902S04","article-title":"3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids infused into the peritoneal cavity cannot be found in plasma","volume":"29","author":"Erixon","year":"2009","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0930","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/089686080802800315","article-title":"3,4-DGE in peritoneal dialysis fluids cannot be found in plasma after infusion into the peritoneal cavity","volume":"28","author":"Erixon","year":"2008","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0935","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1523-1755.2004.00747.x","article-title":"The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane","volume":"66","author":"Williams","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0940","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000368235","article-title":"Effect of neutral pH and low-glucose degradation product-containing peritoneal dialysis solution on residual renal function in peritoneal dialysis patients: a meta-analysis","volume":"129","author":"Wang","year":"2015","journal-title":"Nephron"},{"key":"10.1016\/j.drudis.2016.06.011_bib0945","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2215\/CJN.05410514","article-title":"Effect of neutral-pH, low-glucose degradation product peritoneal dialysis solutions on residual renal function, urine volume, and ultrafiltration: a systematic review and meta-analysis","volume":"10","author":"Yohanna","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"Suppl. 2","key":"10.1016\/j.drudis.2016.06.011_bib0950","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1177\/089686080702702s39","article-title":"The \u2018heart\u2019 of peritoneal dialysis","volume":"27","author":"Wang","year":"2007","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0955","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/089686080502500308","article-title":"Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (balance)","volume":"25","author":"Lee","year":"2005","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0960","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.ajkd.2009.05.014","article-title":"Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions","volume":"54","author":"Han","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.drudis.2016.06.011_bib0965","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ndt\/gfl559","article-title":"Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial","volume":"22","author":"Szeto","year":"2007","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.drudis.2016.06.011_bib0970","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/nep.12375","article-title":"Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients","volume":"20","author":"Wang","year":"2015","journal-title":"Nephrology"},{"key":"10.1016\/j.drudis.2016.06.011_bib0975","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/ndt\/gfl848","article-title":"Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis","volume":"22","author":"Montenegro","year":"2007","journal-title":"Nephrol. Dial. Transpl."},{"key":"10.1016\/j.drudis.2016.06.011_bib0980","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2011121201","article-title":"Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes","volume":"23","author":"Johnson","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.drudis.2016.06.011_bib0985","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/sj.ki.5002574","article-title":"Randomized controlled study of biocompatible peritoneal dialysis solutions: effect on residual renal function","volume":"73","author":"Fan","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0990","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3747\/pdi.2011.00072","article-title":"A new neutral-pH low-GDP peritoneal dialysis fluid","volume":"32","author":"Himmele","year":"2012","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib0995","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3747\/pdi.2011.00270","article-title":"Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis","volume":"33","author":"Kawanishi","year":"2013","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib1000","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1046\/j.1523-1755.2001.0590041529.x","article-title":"Bicarbonate\/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels","volume":"59","author":"Jones","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib1005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/089686080102100605","article-title":"Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis","volume":"21","author":"Krediet","year":"2001","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib1010","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/ki.1996.446","article-title":"IL-1 beta, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: relevance to peritonitis in CAPD","volume":"50","author":"Yung","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib1015","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/089686080602600414","article-title":"How to avoid glucose degradation products in peritoneal dialysis fluids","volume":"26","author":"Erixon","year":"2006","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib1020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1523-1755.2003.00732.x","article-title":"Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid","volume":"63","author":"Ishikawa","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib1025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1523-1755.2000.00182.x","article-title":"Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds","volume":"58","author":"Miyata","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib1030","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/089686089501500212","article-title":"In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis","volume":"15","author":"Wieslander","year":"1995","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib1035","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1053\/ajkd.2003.50086","article-title":"Formation of advanced glycation end products during CAPD","volume":"41","author":"Tauer","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.drudis.2016.06.011_bib1040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/089686089701700413","article-title":"Reduced glucose degradation products in bicarbonate\/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags","volume":"17","author":"Cooker","year":"1997","journal-title":"Perit. Dial. Int."},{"key":"10.1016\/j.drudis.2016.06.011_bib1045","first-page":"17","article-title":"Effect of icodextrin peritoneal dialysis solution on cell proliferation in vitro","volume":"15","author":"Cooker","year":"1999","journal-title":"Adv. Perit. Dial."},{"key":"10.1016\/j.drudis.2016.06.011_bib1050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bj2910529","article-title":"Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production","volume":"291","author":"Hunt","year":"1993","journal-title":"Biochem. J."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964461630229X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964461630229X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:26:36Z","timestamp":1761222396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964461630229X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":105,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S135964461630229X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2016.06.011","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemistry and clinical relevance of carbohydrate degradation in drugs","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2016.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}